BNGO 8-K 2026-09-14

Bionano Genomics, Inc. (BNGO) 8-K dated 2026-09-14 — accession 0001411690-26-000046. This URL is the filing, not the BNGO hub.

Bionano Genomics, Inc. (BNGO) is a medical instruments & supplies company listed on US.

Bionano Genomics, Inc. filed a 8-K on 2026-09-14. Accession 0001411690-26-000046.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BNGO revenue for 2025-12-31 was $28.5M. Net income was -$26.4M. Revenue was down 7.4% from 2024-12-31 to 2025-12-31. BNGO currently screens at market cap $13.4M.

Not investment advice. The BNGO SEC hub lists recent forms. The stock page is the research view.